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摘要
目的:研究核黄素和紫外线(UVA)交联疗法对晚期大泡
性角膜病的疗效。
方法:15 例人工晶状体大泡性角膜病变(PBK)患者参与
研究。 分别于角膜交联前和干预后 1, 6mo,对患者行裂
隙灯检查、视敏度、异物调查表、角膜透明度分级、眼部疼
痛度范围、分析仪角膜厚度分析及超声波角膜厚度测量。
氯化钠溶液处理 1wk 后,去除 8mm 直径范围的中央角膜
上皮,在角膜上频繁点滴核黄素 30min,后行 3min 紫外线
(UVA)照射交联疗法。
结果:15 例患者(5 男,10 女),平均年龄为 66依13 岁。 平
均随访时间 6. 2mo。 治疗后 1mo 全眼角膜透明度统计结
果明显优于术前(P<0. 05)。 6mo 时 8 眼角膜透明度较术
前更佳,5 眼持平,2 眼低于术前(P=0.218)。 70%病患异
物感减弱。 处理后1mo 平均中央角膜厚度(CCT)减少(P<
0. 05)。 6mo 时,除 3 眼外均出现渐进性肿胀,但统计显示
CCT 明显薄于术前(P= 0. 006)。 统计显示术后 1mo 平均
矫正远视力(CDVA)明显优于术前(P=0. 010)。 6mo 后无
显著差异(P=0. 130)。 1mo 痛值统计结果明显优于术前
(P=0. 007)。 但 6mo 平均痛值较 1mo 高,较术前无明显
差异(P=0. 070)。
结论:术后 1mo 结果显示角膜胶原交联疗法可显著改善
角膜透明度、角膜厚度和眼痛。 但是,它对减少 PBK 患者
疼痛和维持角膜透明度方面似乎并无长期持久的效果。
这种方法延长了角膜移植的时间间隔,并提高了角膜内皮
移植术(DSAEK)过程的可视化。
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Abstract
誗AIM: To evaluate the efficacy of riboflavin administration
and ultraviolet A ( UVA) cross - linking on advanced
symptomatic bullous keratopathy.
誗METHODS: Fifteen patients with symptomatic pseudophakic
bullous keratopathy ( PBK) were included. Slit - lamp
examination, visual acuity, foreign body sensation(FBS)
questionnaire, corneal clarity grading, ocular pain
intensity scale and corneal thickness measures with
Pentacam and ultrasound pachymetry ( UP ), were
performed before corneal cross - linking and 1 and 6mo
thereafter. After using sodium chloride solution, for one
week, the central 8mm ( diameter ) of the corneal
epithelium was removed, and cross - linking, with
riboflavin instillation every 3min for 30min, and UVA
irradiation for 30min was performed.
誗RESULTS: Five males and 10 females with mean age of
66依13y were included. Mean follow up time was 6. 2mo.
Corneal transparency in all eyes was statistically
significantly better 1 month after treatment than
preoperatively ( P < 0. 05). At 6mo, however, corneal
transparency was better in 8 eyes, the same in 5 eyes,
and worse in 2 eyes compared with preoperative levels (P=
0. 218 ). Foreign body sensation subsided in 70% of
patients. The average CCT decreased within 1mo after the
procedure ( P < 0. 05 ). At 6mo, all but 3 eyes had
progressive swelling, and the CCT increased; however,
the CCT was still statistically significantly thinner than
preoperatively ( P = 0. 006). The improvement in mean
CDVA from preoperatively to 1mo postoperatively was
statistically significant (P= 0. 010). At 6mo, no significant
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Tel:029鄄82245172摇 82210956摇 摇 Email:IJO. 2000@163. comdifferences were observed (P=0.130). The pain scores at
1mo were statistically significantly better than preoperatively
(P= 0. 007). At 6mo, however the mean pain score was
higher than at 1mo and not statistically significantly
different from the preoperative score (P=0.070).
誗 CONCLUSION: Corneal CXL significantly improved
corneal transparency, corneal thickness, and ocular pain 1
month postoperatively. However, it did not seem to have
a long-lasting effect in decreasing pain and maintaining
corneal transparency in patients with PBK. This procedure
extends the time interval for corneal transplantation and
increases visualization at DSAEK procedure.
誗 KEYWORDS: bullous keratopathy; corneal collagen
cross-linking; corneal edema; pachymetry
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INTRODUCTION
T
he cornea is a transparent and avascular tissue exposed to
the external environment, and it is responsible for
approximately two-thirds of the total refractive power of the
eye. Corneal optical properties are determined by its
transparency, surface smoothness, contour, and refractive
index. Several clinical conditions, especially because of
endothelial dysfunction, can disturb the balance among factors
in the cornea responsible for its transparency resulting in
visual impairment and painful bullous keratopathy
[1]
Specially pseudophakic bullous keratopathy ( PBK ) is
considered a serious complication of intraocular procedures
and is a leading indication for keratoplasty worldwide. The
corneal endothelium controls fluid and solute transport across
the posterior surface of the cornea and actively maintains the
cornea in the slightly dehydrated state that is required for
optical transparency. Bullous keratopathy is caused by
changes in the corneal endothelium, resulting in an abnormal
state of hydration. Excessive corneal hydration can result in
edema of the corneal epithelial layer, creating irregularity at
the optically critical air - tear film interface. In addition,
rupture of epithelial bullae exposes the corneal nerve endings
and results in significant pain, tearing, and conjunctival
hyperemia
[2].
Corneal collagen cross - linking ( CXL ) was recently
introduced for the treatment of progressive keratoconus. The
technique consists of photopolymerization of the stromal fibers
by the combined action of a photosensitizing substance
(riboflavin, vitamin B2) and UV light from a solid-state UV-
A source. Photopolymerization increases the rigidity of the
corneal collagen and its resistance to keratectasia by inducing
additional cross-links between or within collagen fibers.
Wollensaket al and Bott佼s et al
[3-5] showed that the degree of
swelling of the corneal collagenous matrix was inversely related
to the degree of cross -linking. Treated corneas were more
transparent after cross-linking and moist chamber incubation.
Recent studies
[1,4, 6-8] suggest that CXL with riboflavin 0. 1%
and ultraviolet - A ( UVA ) can strengthen interfiber
attachments, reducing the potential space for fluid
accumulation in edematous corneas. Theoretically, stromal
compaction and improvement in optical function are expected
in edematous corneas after CXL. Because of its potential
benefits, CXL has been suggested as an alternative for
managing bullous keratopathy to minimize ocular discomfort,
improve visual acuity, and possibly postpone the need for
keratoplasty
[5-8]. The aim of this study is to evaluate the
safety, efficacy and consequences of UVA CXL in patients
with painful PBK.
SUBJECTS AND METHODS
Subjects摇 Fifteen eyes of 15 consecutive patients diagnosed
with PBK were enrolled in this prospective study. All patients
had standard CXL as an alternative method to minimize
corneal symptoms and postpone keratoplasty. The study was
approved by the internal review boards of the University of
Tabriz and was performed according to the principles of the
Declaration of Helsinki. All patients provided informed
consent before enrollment in the study. All patients had a
complete ophthalmologic examination that included assessment
of corrected distance visual acuity ( CDVA), foreign body
sensation ( FBS ), slit - lamp examination, ultrasound
pachymetry (Corneoscan; Sonogauge, Cleveland,Ohio), and
Scheimpflug corneal tomography ( Pentacam; Oculus
Optikger覿te GmbH, Wetzlar, Germany) were performed to
assess corneal clarity and central corneal thickness both before
and 6mo after the procedure. For precise determination of
corneal thickness we used of mean pachymetry of CCT and 4
points in 4 quadrant at 4mm central optical zone. Corneal
clarity was graded by visual slit-lamp inspection according to
an arbitrary scale, referred to as corneal clarity score, ranging
0 to 4 as follows : 0 = no edema, totally transparent; 1+ =
slight corneal edema, slight loss of transparency; 2 + =
moderate edema, iris details seen; 3 + = intense edema,
some iris details seen; and 4+ = very opaque, no iris details
seen. Ocular pain intensity was assessed by a visual analog
scale as suggested by the National Pain Education Council.
The scale ranged from 0 to 10, with 10 being the most painful
scenario. Foreign body sensation (FBS) also evaluated with a
questionnaire. Patients included in the study had central
corneal edema for at least 4mo with a minimum central corneal
thickness (CCT) of 400滋m and were in the eye bank list
waiting for keratoplasty. Exclusion criteria were corneal
scarring, IOL or vitreous touch to the cornea.
Methods
Cross-linking procedure after corneal deturgescence摇 Using
0.65% sodium chloride solution every 4 to 6 time/ d for 1wk,
corneal treatment was conducted under sterile conditions in
the operating room. Tetracaine 0. 5%, eyedrops were
administered for anesthesia every 15min. The central 8mm
(diameter) of the corneal epithelium were cautiously removed
using a blunt knife. Riboflavin 0.1% solution(10mg of riboflavin-
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Variable
UP CCT
Pre CXL 1mo 6mo
Pentacam CCT
Pre CXL 1mo 6mo
Mean依SD 709依98. 7 608. 3依108. 0 650. 5依112. 5 765. 3依121. 0 708. 6依129. 1 838. 6依196. 7
Median(range) 710(509-928) 621(445-830) 655(446-903) 775(547-1104) 679(556-1004) 768(600-1144)
CCT: Central corneal thickness; UP: Ultrasound pachymetry.
5-phosphate in 10mL of dextran-T-500 20% solution) was
applied every 3min for 30min before irradiation and every
5min during irradiation. The surgeon had to ascertain that
riboflavin was detected in the anterior chamber, by slit-lamp
inspection using blue light, before the initiation of UV
irradiation. Corneal irradiation was performed according to the
manufacturer蒺s instructions ( IROC UV - X; IROC A6,
Zurich, Switzerland). UV-A wavelength was set at 365nm,
and an irradiance of 3mW/ cm
2 was applied for 30min, which
corresponds to a dose of 5. 4J/ cm
[1,9,10]. After treatment, the
ocular surface was washed with 20/ mL balanced salt solution,
medicated with 2 drops of cyclopentolate, and protected with a
soft contact lens. Topical therapy included betamethasone
eyedrops ( 6 times per day, tapered after the fifth
postoperative day), chloramphenicle eyedrops (4 times per
day until epithelial healing), and lubricants. Postoperative
antibiotic treatment was discontinued after complete epithelial
healing and removal of the contact lens. CXL treatment was
performed only once in each patient.
Statistical Analysis 摇 Mean and median central corneal
thickness were calculated for the 2 pachymetry instruments
used in our study. Preoperative CCT was compared with 1-
and 6 -month postoperative measurements in both measured
with the ultrasound pachymetry ( UP) and Pentacam using
Wilcoxon sign rank test. Spearman correlation coefficients
were also calculated to investigate the correlation between
measurements taken by the 2 different equipments. P values
less than 0. 05 were considered statistically significant, and
all data were analyzed with SPSS version17.
RESULTS
Fifteen consecutive patients with PBK were included in the
study. Ten patients were female, and 5 were male. The mean
age of participants was 66依13y (41-83y). In addition, all
participants submitted to either corneal transplant or any other
intraocular surgery had history of corneal edema for at least
4mo. Table 1 shows the pre and post -cross -linking CCT
values from participants. The average CCT decreased within 1
month after the procedure and these values were statistically
significantly different from the preoperative CCT values (P<
0. 05). This phenomenon was observed regardless of the
instrument used to measure the corneal thickness. Complete
corneal healing, measured as total corneal epithelization,
varied from 7d to 1mo.
At 6mo, all but 3 eyes had progressive swelling, and the CCT
increased; however, the central cornea was still statistically
significantly thinner than preoperatively ( P = 0. 006). At
6mo, 2 eyes had increased CCT over preoperative levels. 6
eyes had a recurrence of microbullae, and 3 had macrobullae.
Eleven patients remained asymptomatic until their last study
visit. Four participants complained about foreign body sensation
at the 6-mo follow-up. No postoperative complications such as
persistent corneal scarring, haze, severe inflammation, or
lenticular opacification were observed until the 6-mo follow-up
visit in any other participant. We observed a high statistically
significant correlation between the UP and Pentacaminstruments
measured by the Spearman correlation coefficients: 0. 80 for
preoperative, 0.89 for 1-mo postoperative, and 0. 89 for 6-mo
postoperative (P<0.05 for all values).
Corneal transparency in all eyes was statistically significantly
better 1 month after treatment than preoperatively (P<0. 05).
At 6mo corneal transparency was better in 8 eyes, the same in
5 eyes, and worse in 2 eyes compared with preoperative
levels. The decrease in the transparency was not statistically
significant, however (P=0.218). The CDVA was better in 9
eyes at 1mo and in 5 eyes at 6mo. The improvement in mean
CDVA from preoperatively to 1mo postoperatively was
statistically significant (P = 0. 010). At 6mo, no significant
differences were observed (P = 0. 130). The pain scores at
1mo were statistically significantly better than preoperatively
(P=0. 007). At 6mo, however, 6 of 15 patients required a
therapeutic contact lens to control pain and the mean pain
score was higher than at 1mo and not statistically significantly
different from the preoperative score (P=0.070).
DISCUSSION
The incidence of corneal edema has increased in the past
decades, especially because of the increased number of
intraocular surgeries being performed, mainly cataract
surgeries. Postsurgical persistent corneal edema has been one
of the main indications for penetrating keratoplasty
[1,11,12].
Corneal transplantation remains the definitive treatment for
endothelial dysfunction. A successful procedure provides both
visual rehabilitation and relief of symptoms. However,
immediate keratoplasty is not a reality in many countries, and
the time spent waiting for a donated cornea could range from
weeks to years
[1,13]. Among the options for the management of
painful bullous keratopathy, several treatment modalities have
been proposed. Topical hypertonic solutions can reduce
epithelial edema, although it has little effect on stromal
edema
[1,14]. Therapeutic soft contact lenses are useful to
relieve discomfort but carry the risk of infection
[1,15]. Surgical
procedures include anterior stromal cauterization, manual
anterior stromal puncture or anterior stromal puncture aided
with yttrium - aluminum - garnet laser
[16,17], excimer laser
phototherapeutic keratectomy
[18], conjunctival flaps, and
amniotic membrane transplantation
[19]. Some of these
approaches could only bring short-term relief of symptoms or
could interfere on the visual recovery after penetrating
keratoplasty. In recent years CXL with riboflavin has been
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riboflavin causes new bonds to form across adjacent collagen
strands in the stromal layer of the cornea, which increases the
cornea蒺s biomechanical strength. In patients with bullous
keratopathy, the corneal extracellular spaces between collagen
fibers accumulate fluids. After CXL, the fibers would
theoretically be more compact, thus reducing corneal
edema
[6,8]. In a study of the hydration behavior of porcine
corneas cross linked with riboflavin and UVA, Wollensak
et al
[3] found beneficial effects of CXL in corneal edema. The
behavior of previously cross - linked corneas was better
compared to those not previously cross - linked, showing
decreased CCT and improved corneal transparency. These
findings are theoretically a consequence of stromal compaction
after CXL
[8].
One advantage of corneal cross-linking is the absence of scars
on the corneal surface, allowing the performance of techniques
such as the deep lamellar endothelial keratoplasty or the
descemet stripping endothelial keratoplasty for the visual
recovery of patients. Other methods such as anterior stromal
micropuncture or cauterization lead to scarring of the corneal
surface, leaving the penetrating keratoplasty as the only
therapeutic option for these cases
[1]. All patients in our study
had an important reduction on corneal thickness after
treatment, and this effect was probably a consequence of the
cross - linking procedure itself, which included corneal
deepithelialization and the hyperosmolar effect of the riboflavin
-dextran solution. However, at the 1-mo follow-up visit,
corneas remained thinner than before the procedure. In an
attempt to overcome the limitations imposed by increased
corneal thickness in patients with bullous keratopathy,
modifications in the surgical technique have been proposed to
maintain reproducible and efficient UVA light riboflavin
penetration in the stroma. Krueger et al
[6,8]. propose
intrastromal delivery of riboflavin with 2 pockets created by a
femtosecond laser. It is important to note that Wollensak et
al
[7]used 40% glucose for 1d before cross-linking in his case
series that allowed a better control of the corneal thickness
before the procedure. In addition, whereas the Wollensak et
al
[9,20] standard protocol recommends a 5 - min application
period of riboflavin/ dextran before the irradiation, we chose a
30-min application period as proposed by Spoerl et al
[10]also
leading to a reduction of corneal thickness before cross -
linking because of the dextran. Some participants had
recurrence of symptoms and epithelial bullae formation. Ten
individuals developed bullous edema between 1 and 5mo after
the procedure, and 4 developed bullousedema after 6mo. As
mentioned previously the cross - linking procedure does not
cause scarring of anterior corneal surface, and it might reduce
anterior stromal edema, resulting in less epithelial edema and
a smoother surface. However, in advanced cases of
endothelial failure, the effect of crosslinking might not be
strong enough to avoid recurrence of corneal edema and
bullous keratopathy. From this case series, we observed that
those with more advanced corneal edema had little short-term
benefits. These patients usually have a significantly impaired
endothelial function and thicker corneas, which may interfere
with riboflavin diffusion in the stroma resulting in less
benefit
[1]. Other previous studies
[6, 8] report an improvement
in corneal transparency. In our study, we also observed an
initial improvement in corneal transparency, although it did
not last more than 6mo. In corneal edema, the interfiber
collagen spacing is increased because of fluid accumulation.
The compaction of fibers in the stroma, combined with an
enhanced resistance to osmotic and hydrostatic fluid
accumulation after the crosslinking procedure, indicates that
this technique could be useful in patients with corneal
edema
[3,21]. We observed an increase of CCT measured by
both instruments after the first month of follow-up. Former
studies also demonstrated similar results but with fewer cases.
The increase of CCT over time might be explained by the fact
that fluid could have infiltrated through newly formed bonds.
In addition, this effect could have been influenced by the
residual endothelial function
[1,3]. Besides means
[8,21]
urements done by the UP, Pentacam was used. Studies have
shown high correlation between measurements of corneal
thickness using ultrasound pachymetry, Pentacam and anterior
segment OCT. However, the OCT has underestimated
pachymetric measurements in some studies and overestimated
in others compared with the UP. The reasons for these
differences were not clear
[22,23].
Consistent with Krueger et al
[6] study, in our study the
clinical outcomes were improved; VA increased, bullous
changes of epithelium improved, FBS decreased and corneal
thickness reduced, but their procedure was different and they
used two consecutive corneal pockets (350 and 150滋m deep)
that were created using a femtoseconed laser and sequential
intrastromal injection of 0. 1% riboflavin. Constantin et al
[24]
showed that one month after CXL, a gradual reduction of
corneal edema was observed with subsequent improvement of
the corneal clarity and corneal epithelium integrity and an
improvement of the symptoms without any side effects.
Constantine et al
[24] procedure and results was similar with
ours, but their sample size (1 eye) and follow - up time
(1mo) was not enough to evaluate the effects of CXL on PBK
parameters. Bikbov G study
[28]with similar to ours procedure
and one year follow-up time in 9 eyes of BK, showed that,
the VA raised in all patients, the pain subsided and corneal
edema (thickness) reduced by 99. 05滋m in 11. 8mo. In our
study the corneal thickness reduced 74滋m in 6mo,
postoperatively. Gadelha et al
[26] treated 12 eyes with similar
procedure and 2mo, fallow - up time. They reported,
significant pain reduction (P<0. 001) but corneal thickness
and VA measurements presented with no significant
difference. Outcomes of Gharaee et al
[27] study with standard
procedure after 6 months follow-up, indicated CXL is not an
effective treatment for bullous keratopathy with respect to VA
and CCT, although it can improve irritation and discomfort.
In contrast with Gharaee et al
[27]and Gadelha et al
[26]studies,
our study after 6 month leads to improving of VA in 70% and
reducing of corneal thickness by 80% of eyes. Similar to their
studies, pain and FBS improved in 70% of eyes, in our
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[1] interventional case series
included 25 eyes with corneal edema demonstrated that, mean
CCT, measured by ultrasound and OCT, decreased
significantly after 1 and 3mo. 14 (56%) patients developed
new epithelial bullae and 11 (44%) patients, remained
asymptomatic until their last visit. In our intervention 3
patients (30%) developed new epithelial bullae, but only
one of them increased corneal thickness. In other one patient,
corneal thickness increased by 177滋m but no developed new
epithelial bullae.
Limitations of our study was the lack of a control group and
short follow up time. Our study suggests that corneal collagen
cross-linking reduced corneal edema temporarily. This effect
was demonstrated through the reduction of corneal thickness of
the patients submitted to this treatment. The procedure was
demonstrated to be safe with few complications. Although the
effect seemed to be moderate in most cases, it still provided
relief of symptoms to many patients in this study, indicating
that this procedure might be helpful for patients with bullous
keratopathy awaiting
penetrating keratoplasty. Future studies will help determine
the profile of individuals with corneal edema who will get the
most benefit from this procedure
[1]. In conclusion and
according previous studies mentioned above, our study,
confirmed that; using of CXL for treating of PBK leads to
compaction of corneal stroma, decreases corneal thickness,
pain and FBS, increases corneal clarity and VA, in short time
after cross - linking, thus supplies the patient蒺s comfort,
extends the time of interval for corneal transplantation and
increases visualization during DSAEK procedure. But, it
seems that, due to sustained endothelial disfunction, the
symptoms will be reversible, and further clinical studies with
longer follow-up period are needed to accurate evaluation of
these early changes.
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